Impulsivity and risk taking in bipolar disorder and schizophrenia LF Reddy, J Lee, MC Davis, L Altshuler, DC Glahn, DJ Miklowitz, ... Neuropsychopharmacology 39 (2), 456-463, 2014 | 195 | 2014 |
Oxytocin-augmented social cognitive skills training in schizophrenia MC Davis, MF Green, J Lee, WP Horan, D Senturk, AD Clarke, SR Marder Neuropsychopharmacology 39 (9), 2070-2077, 2014 | 156 | 2014 |
Effects of single dose intranasal oxytocin on social cognition in schizophrenia MC Davis, J Lee, WP Horan, AD Clarke, MR McGee, MF Green, ... Schizophrenia research 147 (2-3), 393-397, 2013 | 152 | 2013 |
Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis Z Wang, YP Rong, MH Malone, MC Davis, F Zhong, CW Distelhorst Oncogene 25 (13), 1903-1913, 2006 | 132 | 2006 |
Bcl-2 differentially regulates Ca2+ signals according to the strength of T cell receptor activation F Zhong, MC Davis, KS McColl, CW Distelhorst The Journal of cell biology 172 (1), 127-137, 2006 | 128 | 2006 |
Disorders of orgasm in women: A literature review of etiology and current treatments WW IsHak, A Bokarius, JK Jeffrey, MC Davis, Y Bakhta The Journal of Sexual Medicine 7 (10), 3254-3268, 2010 | 103 | 2010 |
Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial CL Raison, G Sanacora, J Woolley, K Heinzerling, BW Dunlop, RT Brown, ... Jama 330 (9), 843-853, 2023 | 96 | 2023 |
Psychopharmacology of the negative symptoms: current status and prospects for progress MC Davis, WP Horan, SR Marder European Neuropsychopharmacology 24 (5), 788-799, 2014 | 77 | 2014 |
Discontinuation of clozapine: a 15‐year naturalistic retrospective study of 320 patients MC Davis, MA Fuller, ME Strauss, PE Konicki, GE Jaskiw Acta Psychiatrica Scandinavica 130 (1), 30-39, 2014 | 63 | 2014 |
Anti-N-methyl-D-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management JL Kruse, JK Jeffrey, MC Davis, J Dearlove, WW IsHak, JO Brooks Ann Clin Psychiatry 26 (2), 111-119, 2014 | 61 | 2014 |
Associations between oxytocin receptor genotypes and social cognitive performance in individuals with schizophrenia MC Davis, WP Horan, EL Nurmi, S Rizzo, W Li, CA Sugar, MF Green Schizophrenia research 159 (2-3), 353-357, 2014 | 54 | 2014 |
The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study JK Wynn, MF Green, G Hellemann, K Karunaratne, MC Davis, SR Marder Schizophrenia research 195, 572-573, 2018 | 44 | 2018 |
The role of dopaminergic agents in improving quality of life in major depressive disorder WW IsHak, M Davis, J Jeffrey, K Balayan, RN Pechnick, K Bagot, ... Current psychiatry reports 11 (6), 503-508, 2009 | 30 | 2009 |
Efficient trial design-FDA approval of valbenazine for tardive dyskinesia MC Davis, BJ Miller, JK Kalsi, T Birkner, MV Mathis The New England journal of medicine 376 (26), 2503-2506, 2017 | 29 | 2017 |
Dexamethasone-induced inositol 1, 4, 5-trisphosphate receptor elevation in murine lymphoma cells is not required for dexamethasone-mediated calcium elevation and apoptosis MC Davis, KS McColl, F Zhong, Z Wang, MH Malone, CW Distelhorst Journal of biological chemistry 283 (16), 10357-10365, 2008 | 23 | 2008 |
Serum IL-18 level, clinical symptoms and IL-18-607A/C polymorphism among chronic patients with schizophrenia in a Chinese Han population XY Zhang, YL Tan, DC Chen, SP Tan, MZ Malouta, JD Bernard, ... Psychoneuroendocrinology 68, 140-147, 2016 | 18 | 2016 |
Live free or die: an immature T cell decision encoded in distinct Bcl-2 sensitive and insensitive Ca2+ signals MC Davis, CW Distelhorst Cell Cycle 5 (11), 1171-1174, 2006 | 17 | 2006 |
Effect of paroxetine or quetiapine combined with oxycodone vs oxycodone alone on ventilation during hypercapnia: a randomized clinical trial J Florian, R van der Schrier, V Gershuny, MC Davis, C Wang, X Han, ... Jama 328 (14), 1405-1414, 2022 | 14 | 2022 |
Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the rat L Xu, A Krishna, S Stewart, K Shea, R Racz, JL Weaver, DA Volpe, ... Clinical and Translational Science 14 (6), 2208-2219, 2021 | 13 | 2021 |
Developing an animal model to detect drug–drug interactions impacting drug-induced respiratory depression L Xu, A Chockalingam, S Stewart, K Shea, MK Matta, S Narayanasamy, ... Toxicology Reports 7, 188-197, 2020 | 9 | 2020 |